Lupin Limited has informed the Exchange regarding a press release dated May 13, 2025, titled "Lupin Launches Tolvaptan Tablets in the U.S. with 180-Day Exclusivity ".
Lupin Limited has informed the Exchange regarding a press release dated May 13, 2025, titled "Lupin Launches Tolvaptan Tablets in the U.S. with 180-Day Exclusivity ".